Josbert M. Metselaar

7.5k total citations · 2 hit papers
101 papers, 5.7k citations indexed

About

Josbert M. Metselaar is a scholar working on Biomaterials, Molecular Biology and Immunology. According to data from OpenAlex, Josbert M. Metselaar has authored 101 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Biomaterials, 33 papers in Molecular Biology and 30 papers in Immunology. Recurrent topics in Josbert M. Metselaar's work include Nanoparticle-Based Drug Delivery (36 papers), RNA Interference and Gene Delivery (15 papers) and Immunotherapy and Immune Responses (13 papers). Josbert M. Metselaar is often cited by papers focused on Nanoparticle-Based Drug Delivery (36 papers), RNA Interference and Gene Delivery (15 papers) and Immunotherapy and Immune Responses (13 papers). Josbert M. Metselaar collaborates with scholars based in Netherlands, Germany and United States. Josbert M. Metselaar's co-authors include Gert Storm, Twan Lammers, Susan Hua, María Matos, Raymond M. Schiffelers, Marca H. M. Wauben, Otto C. Boerman, Manuela Banciu, Josée P.A. Wagenaar-Hilbers and Wim E. Hennink and has published in prestigious journals such as Chemical Society Reviews, Physical review. B, Condensed matter and ACS Nano.

In The Last Decade

Josbert M. Metselaar

101 papers receiving 5.6k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

2018 677 citations Susan Hua, María Matos et al. Frontiers in Pharmacology profile →
Metallodrugs in cancer nanomedicine

2022 160 citations Quim Peña, Alec Wang et al. Chemical Society Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Josbert M. Metselaar Netherlands	42	2.0k	1.9k	1.3k	1.0k	587	101	5.7k
Robbert J. Kok Netherlands	44	3.0k 1.5×	1.7k 0.9×	1.2k 0.9×	614 0.6×	614 1.0×	136	6.4k
Gianfranco Pasut Italy	36	3.2k 1.6×	2.7k 1.4×	1.4k 1.0×	417 0.4×	550 0.9×	109	7.1k
Anna Schwendeman United States	34	2.2k 1.1×	1.4k 0.7×	2.2k 1.6×	1.9k 1.8×	368 0.6×	113	5.9k
János Szebeni Hungary	53	3.8k 1.9×	3.6k 1.9×	2.0k 1.5×	2.4k 2.3×	975 1.7×	168	10.4k
Youngro Byun South Korea	49	3.2k 1.6×	2.1k 1.1×	1.6k 1.2×	446 0.4×	1.2k 2.0×	261	7.8k
Joy Wolfram United States	46	3.4k 1.7×	1.5k 0.8×	1.6k 1.2×	537 0.5×	240 0.4×	96	5.8k
Huan Wang China	37	1.7k 0.9×	753 0.4×	912 0.7×	607 0.6×	316 0.5×	208	4.4k
Crispin R. Dass Australia	54	5.7k 2.8×	2.3k 1.2×	1.8k 1.3×	570 0.6×	1.2k 2.0×	223	11.5k
Qingguo Xu United States	33	4.5k 2.2×	2.4k 1.3×	1.9k 1.4×	523 0.5×	1.4k 2.4×	84	9.1k
Marissa E. Wechsler United States	16	2.3k 1.2×	2.1k 1.1×	2.3k 1.7×	544 0.5×	541 0.9×	25	6.1k

Countries citing papers authored by Josbert M. Metselaar

Since Specialization

Citations

This map shows the geographic impact of Josbert M. Metselaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josbert M. Metselaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josbert M. Metselaar more than expected).

Fields of papers citing papers by Josbert M. Metselaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josbert M. Metselaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josbert M. Metselaar. The network helps show where Josbert M. Metselaar may publish in the future.

Co-authorship network of co-authors of Josbert M. Metselaar

This figure shows the co-authorship network connecting the top 25 collaborators of Josbert M. Metselaar. A scholar is included among the top collaborators of Josbert M. Metselaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josbert M. Metselaar. Josbert M. Metselaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorenzi, Federica De, Diana Moeckel, Eva Miriam Buhl, et al.. (2025). Hydrophobic ion pairing enables co-loading of water-soluble drugs in polymeric micelles. Journal of Controlled Release. 382. 113748–113748. 1 indexed citations

Metselaar, Josbert M., Twan Lammers, Roland Fenk, et al.. (2023). A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma. Drug Delivery and Translational Research. 13(4). 915–923. 6 indexed citations

Wang, Alec, Marek Weiler, Eva Miriam Buhl, et al.. (2023). Effect of Radical Polymerization Method on Pharmaceutical Properties of Π Electron-Stabilized HPMA-Based Polymeric Micelles. Biomacromolecules. 24(10). 4444–4453. 2 indexed citations

Guerzoni, Luis P. B., Abdolrahman Omidinia‐Anarkoli, Laura De Laporte, et al.. (2022). Liposome manufacturing under continuous flow conditions: towards a fully integrated set-up with in-line control of critical quality attributes. Lab on a Chip. 23(1). 182–194. 18 indexed citations

Peña, Quim, Alec Wang, Orysia Zaremba, et al.. (2022). Metallodrugs in cancer nanomedicine. Chemical Society Reviews. 51(7). 2544–2582. 160 indexed citations breakdown →

Chen, Yinan, Hans W. Scheeren, Josbert M. Metselaar, et al.. (2020). A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase. Pharmaceutics. 12(6). 536–536. 10 indexed citations

Dadfar, Seyed Mohammadali, Milita Darguzyte, Karolin Roemhild, et al.. (2020). Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance. Journal of Nanobiotechnology. 18(1). 22–22. 161 indexed citations

Lammers, Twan, Alexandros Marios Sofias, Roy van der Meel, et al.. (2020). Dexamethasone nanomedicines for COVID-19. Nature Nanotechnology. 15(8). 622–624. 147 indexed citations

Kuninty, Praneeth R., Ruchi Bansal, Susanna W.L. de Geus, et al.. (2019). ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Science Advances. 5(9). eaax2770–eaax2770. 97 indexed citations

10.

Bagheri, Mahsa, Gert Storm, Josbert M. Metselaar, et al.. (2019). Scale-Up of the Manufacturing Process To Produce Docetaxel-Loaded mPEG-b-p(HPMA-Bz) Block Copolymer Micelles for Pharmaceutical Applications. Organic Process Research & Development. 23(12). 2707–2715. 15 indexed citations

11.

Hua, Susan, María Matos, Josbert M. Metselaar, & Gert Storm. (2018). Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization. Frontiers in Pharmacology. 9. 790–790. 677 indexed citations breakdown →

12.

Bagheri, Mahsa, Aida Varela-Moreira, Olivier Sandre, et al.. (2018). Effect of Formulation and Processing Parameters on the Size of mPEG-b-p(HPMA-Bz) Polymeric Micelles. Langmuir. 34(50). 15495–15506. 62 indexed citations

13.

Beztsinna, Nataliia, Bo Lou, Tomáš Etrych, et al.. (2017). Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin. Nanoscale. 9(29). 10404–10419. 57 indexed citations

14.

Terry, Samantha Y.A., Otto C. Boerman, Danny Gerrits, et al.. (2015). 111In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages. European Journal of Nuclear Medicine and Molecular Imaging. 42(9). 1430–1438. 26 indexed citations

15.

Lobatto, Mark E., Claudia Calcagno, Antoine Millon, et al.. (2015). Atherosclerotic Plaque Targeting Mechanism of Long-Circulating Nanoparticles Established by Multimodal Imaging. ACS Nano. 9(2). 1837–1847. 102 indexed citations

16.

Metselaar, Josbert M., Danny Gerrits, P.L. van Lent, et al.. (2015). [ 18 ]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis. Journal of Controlled Release. 209. 20–26. 21 indexed citations

17.

Laverman, Peter, Danny Gerrits, Gerben M. Franssen, et al.. (2015). Comparison of three remote radiolabelling methods for long-circulating liposomes. Journal of Controlled Release. 220(Pt A). 239–244. 23 indexed citations

18.

Lobatto, Mark E., Claudia Calcagno, Josbert M. Metselaar, et al.. (2012). Imaging the Efficacy of Anti-Inflammatory Liposomes in a Rabbit Model of Atherosclerosis by Non-Invasive Imaging. Methods in enzymology on CD-ROM/Methods in enzymology. 508. 211–228. 22 indexed citations

19.

Schweingruber, Nils, Jens van den Brandt, Josbert M. Metselaar, et al.. (2011). Liposomal Encapsulation of Glucocorticoids Alters Their Mode of Action in the Treatment of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 187(8). 4310–4318. 57 indexed citations

20.

Metselaar, Josbert M. & Gert Storm. (2005). Liposomes in the treatment of inflammatory disorders. Expert Opinion on Drug Delivery. 2(3). 465–476. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact